Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report) Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report)

Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report‪)‬

Clinical Chemistry 2001, August, 47, 8

    • $5.99
    • $5.99

Publisher Description

Medical tests are central to modern medicine and require better characterization than has been the norm in the past. Tests must be characterized in several important ways (Table 1). Conceptually, the first step is to determine the analytical features of a new test. Clinical chemists have focused on (and are the traditional experts on) analytical features: precision, accuracy (or "trueness"), detection limits, linearity, interferences, and so forth. This focus is clearly evident from the "Information for Authors" of Clinical Chemistry (1), and articles in this Journal and elsewhere have exemplified the high standards of clinical chemists in defining the analytical performance of tests. Clinical chemists have also been active in other areas of test evaluation. They are among the foremost pioneers in the characterization of nonanalytical factors related to tests, including within- and between-person biological variation. In recent years, clinical chemists and clinical epidemiologists have stressed the need to improve the characterization of the diagnostic accuracies of tests (2,3). Indeed, the "Information for Authors" of Clinical Chemistry (1) now contains a checklist (3) of items to include in studies of diagnostic accuracy. By contrast, neither clinical chemists nor others have focused as intently on studies of the clinical usefulness of tests.

GENRE
Science & Nature
RELEASED
2001
August 1
LANGUAGE
EN
English
LENGTH
18
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
177
KB
Test Research Versus Diagnostic Research (Opinion) Test Research Versus Diagnostic Research (Opinion)
2004
Statistical Issues in Drug Research and Development Statistical Issues in Drug Research and Development
2017
The Quality of Clinical Trials with Harpagophytum Procumbens (Review) The Quality of Clinical Trials with Harpagophytum Procumbens (Review)
2003
An Evidence Framework for Genetic Testing An Evidence Framework for Genetic Testing
2017
Errors in Laboratory Medicine (Minireview) Errors in Laboratory Medicine (Minireview)
2002
Compliance of General Practitioners with a Guideline-Based Decision Support System for Ordering Blood Tests (Evidence-Based Laboratory Medicine and Test Utilization) Compliance of General Practitioners with a Guideline-Based Decision Support System for Ordering Blood Tests (Evidence-Based Laboratory Medicine and Test Utilization)
2002
Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs) Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs)
2005
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor) Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor)
1998
Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition) Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition)
2003